FRANKFURT (Reuters) – Siemens said it has agreed to buy Luxembourg-based Fast Track Diagnostics to boost its molecular-testing offering, one of the areas it is keen to expand as it prepares to float its healthcare unit, Healthineers.

Siemens buys Fast Track Diagnostics to boost molecular offering

Any comments?

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.